[Event Report] The Fourth Advisory Board Meeting for the Immunization and Vaccination Policy Promotion Project, “Communication Strategy for Promoting Public Understanding and Enlightenment of Vaccine and Immunization” (February 19, 2021)

date : 3/17/2021

Health and Global Policy Institute (HGPI) held the Fourth Advisory Board Meeting for the Immunization and Vaccination Policy Promotion Project, entitled “Communication Strategy for Promotion of Public Understanding and Enlightenment about Vaccine and Immunization.”

Following the discussion at the first meeting, the fourth advisory board meeting focused on good practices and lessons learned from the national government, local municipalities, medical institutions, and the media following the National Immunization Plan.
Due to the circumstances regarding the COVID-19 pandemic, this meeting was held online.

■Overview
Date & Time: Friday, Februrary 19, 2021
Organizer: Health and Global Policy Institute

■Advisory Board Members and Observers (alphabetical order by last name)

Members:

Kyoko Ama (Former Representative, Ippan Shadan Hojin Shiro Shoni Iryo Mamoro Kodomo-tachi no Kai)
Hidenori Arai (President, National Center for Geriatrics and Gerontology; Vice President, The Japan Geriatrics Society)
Satoshi Iwata (Department of Infectious Diseases, National Cancer Center Hospital)
Isao Miyairi (Medical Director, Department of Infectious Diseases, National Center for Child Health and Development)
Kuniko Nakayama (Director, My Family Clinic Gamagori, Medical Association Mefa Jinaikai)
Leon Ochiai (Head, Public Relations Division, Responsible for Vaccine, Sanofi K.K.)
Akihiko Saitoh (Professor, Department of Pediatrics, Graduate School of Medical and Dental Sciences, Niigata University)
Akinori Sugaya (Head Physician, Sugaya Children’s Clinic; Director, KNOW VPD Protect Our Children)
Mugen Ujiie (Director of Travel Clinic, Director of Immunization Support Center, Disease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine (NCGM))

Observers:

Masayuki Imagawa (Representative Director, Japan Vaccine Industry Association (President))
Yoko Katakura (Director, Public Affairs & Policy, Responsible for Vaccines, Pfizer K.K.)
Shiori Masuda (Chief, Vaccine Market Access Division, GlaxoSmithKline K.K.)
Shinji Matsumoto (Chair, Vaccines Working Team, EFPIA Japan)
Naokazu Saito (Director, Policy Intelligence Department, Janssen Pharmaceutical K.K.)
Daisaku Sato (Chief Management Officer, Pharmaceuticals and Medical Devices Agency, Japan)
Naoki Shimizu (Public Relations Division, Responsible for Vaccine, Sanofi K.K.)
Keiko Tanaka-Taya (Chief, Division of Immunization Program, Infectious Disease Surveillance Center, National Institute of Infectious Diseases)